Synthesis and Biological Evaluation of Novel Pyridazinone-Based α<sub>4</sub>Integrin Receptor Antagonists
Yong Gong(Johnson & Johnson (United States)), Wei He(Hebei Medical University), Nathaniel Wallace(Johnson & Johnson (United States)), M. Carolyn Fisher(Johnson & Johnson (United States)), Patricia Andrade‐Gordon(Springhouse), Tamara A. Miskowski(Janssen (United States)), John A. Masucci(Johnson & Johnson (United States)), Pamela J. Hornby(Springhouse), Stephen M. Prouty(Johnson & Johnson (United States)), Bruce E. Maryanoff(Johnson & Johnson (United States)), Dennis J. Hlasta(Johnson & Johnson (United States)), J. Kent Barbay(Johnson & Johnson (United States)), Alexey B. Dyatkin(Janssen (United States)), William Hageman(Johnson & Johnson (United States)), Edward S. Kimball(Johnson & Johnson (United States)), Rosemary J. Santulli(Johnson & Johnson (United States)), Craig R. Schneider(Johnson & Johnson (United States)), Bruce P. Damiano(Johnson & Johnson (United States)), Scott Ballentine(Johnson & Johnson (United States))
Cited by 38
Related Papers
The pharmacology and therapeutic applications of monoclonal antibodies
|Pharmacology Research & Perspectives|2019|346
<i>C</i>-Glycosidation Technology With Free Radical Reactions
|Synlett|1998|151
Early-Onset Preeclampsia Is Associated With Gut Microbial Alterations in Antepartum and Postpartum Women
|Frontiers in Cellular and Infection Microbiology|2019|150
Modulation of gastrointestinal function by MuDelta, a mixed µ opioid receptor agonist/ µ opioid receptor antagonist
|British Journal of Pharmacology|2012|121
Alternative functional in vitro models of human intestinal epithelia
|Frontiers in Pharmacology|2013|108